(Q38973996)

8 September 2017

High expression of the histone demethylase LSD1 associates with cancer cell proliferation and unfavorable prognosis in tongue cancer (English)

1 reference

8 September 2017

Chunping Yuan

1

1 reference

8 September 2017

Zhongwu Li

2

1 reference

8 September 2017

Bing Qi

3

1 reference

8 September 2017

Wei Zhang

4

1 reference

8 September 2017

Jie Cheng

5

1 reference

8 September 2017

Yanling Wang

6

1 reference

8 September 2017

18 July 2014

1 reference

Journal of Oral Pathology & Medicine

8 September 2017

1 reference

8 September 2017

44

1 reference

8 September 2017

2

1 reference

8 September 2017

159-165

1 reference

8 September 2017

1 reference

Recent advances in Oral Oncology 2008; squamous cell carcinoma aetiopathogenesis and experimental studies

21 January 2018

1 reference

Prognostic evaluation of oral tongue cancer: means, markers and perspectives (I).

21 January 2018

1 reference

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

Histone lysine demethylases: emerging roles in development, physiology and disease

21 January 2018

1 reference

Histone demethylation mediated by the nuclear amine oxidase homolog LSD1

21 January 2018

1 reference

p53 is regulated by the lysine demethylase LSD1

21 January 2018

1 reference

The histone LSD1 demethylase in stemness and cancer transcription programs

21 January 2018

1 reference

Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition

21 January 2018

1 reference

High expression of lysine-specific demethylase 1 correlates with poor prognosis of patients with esophageal squamous cell carcinoma.

21 January 2018

1 reference

Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers

21 January 2018

1 reference

The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer

21 January 2018

1 reference

Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer

21 January 2018

1 reference

KDM1 is a novel therapeutic target for the treatment of gliomas

21 January 2018

1 reference

Lysine-specific histone demethylase 1 (LSD1): A potential molecular target for tumor therapy

21 January 2018

1 reference

Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis

21 January 2018

1 reference

The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer

21 January 2018

1 reference

The lysine-specific demethylase 1 is required for cell proliferation in both p53-dependent and -independent manners

21 January 2018

1 reference

LSD1-mediated epigenetic modification contributes to proliferation and metastasis of colon cancer

21 January 2018

1 reference

Histone lysine demethylases as targets for anticancer therapy

21 January 2018

1 reference

LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells.

21 January 2018

1 reference

Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia

21 January 2018

1 reference

Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner.

21 January 2018

1 reference

Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JOP.12220

1 reference

8 September 2017

1 reference